OMNICELL, INC.OMCLEarnings & Financial Report
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.
Revenue
$310.6M
Gross Profit
$134.5M
Operating Profit
$8.2M
Net Profit
$5.5M
Gross Margin
43.3%
Operating Margin
2.7%
Net Margin
1.8%
YoY Growth
10.0%
EPS
$0.12
Financial Flow
OMNICELL, INC. Q3 2025 Financial Summary
OMNICELL, INC. reported revenue of $310.6M (up 10.0% YoY) for Q3 2025, with a net profit of $5.5M (down 36.7% YoY) (1.8% margin). Cost of goods sold was $176.1M, operating expenses totaled $126.3M.
Key Financial Metrics
| Total Revenue | $310.6M |
|---|---|
| Net Profit | $5.5M |
| Gross Margin | 43.3% |
| Operating Margin | 2.7% |
| Report Period | Q3 2025 |
Revenue Breakdown
OMNICELL, INC. Q3 2025 revenue of $310.6M breaks down across 4 segments, led by Connected Devices Software Licenses And Other at $152.6M (49.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Connected Devices Software Licenses And Other | $152.6M | 49.1% |
| Technical Services | $67.3M | 21.7% |
| Saa S And Expert Services | $65.9M | 21.2% |
| Consumables | $24.9M | 8.0% |
OMNICELL, INC. Revenue by Segment — Quarterly Trend
OMNICELL, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Connected Devices Software Licenses And Other and Technical Services) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Connected Devices Software Licenses And Other | $154.2M | $152.6M | $138.6M | $120.1M |
| Technical Services | $67.6M | $67.3M | — | $61.4M |
| Saa S And Expert Services | $66.5M | $65.9M | — | $63.1M |
| Consumables | $25.6M | $24.9M | $24.6M | $25.1M |
OMNICELL, INC. Annual Revenue by Year
OMNICELL, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.1B |
| 2023 | $1.1B |
| 2022 | $1.3B |
OMNICELL, INC. Quarterly Revenue & Net Profit History
OMNICELL, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $314.0M | +2.3% | N/A | N/A |
| Q3 2025 | $310.6M | +10.0% | $5.5M | 1.8% |
| Q2 2025 | $290.6M | +5.0% | $5.6M | 1.9% |
| Q1 2025 | $269.7M | +9.6% | $-7.0M | -2.6% |
| Q4 2024 | $306.9M | +18.6% | N/A | N/A |
| Q3 2024 | $282.4M | -5.4% | $8.6M | 3.1% |
| Q2 2024 | $276.8M | -7.4% | $3.7M | 1.3% |
| Q1 2024 | $246.2M | -15.3% | $-15.7M | -6.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $246.2M | $276.8M | $282.4M | $306.9M | $269.7M | $290.6M | $310.6M | $314.0M |
| YoY Growth | -15.3% | -7.4% | -5.4% | 18.6% | 9.6% | 5.0% | 10.0% | 2.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.28B | $2.29B | $2.30B | $2.12B | $2.15B | $2.15B | $1.95B | $1.97B |
| Liabilities | $1.10B | $1.09B | $1.07B | $877.6M | $894.4M | $881.9M | $727.7M | $742.9M |
| Equity | $1.19B | $1.20B | $1.23B | $1.24B | $1.26B | $1.26B | $1.22B | $1.23B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $50.0M | $58.7M | $22.8M | $56.3M | $25.9M | $42.8M | $28.3M | $30.4M |